Psyence Biomedical Stock Forecast - Double Exponential Smoothing

PBM Stock  USD 3.51  0.17  5.09%   
The Double Exponential Smoothing forecasted value of Psyence Biomedical Ltd on the next trading day is expected to be 3.51 with a mean absolute deviation of 0.59 and the sum of the absolute errors of 34.83. Psyence Stock Forecast is based on your current time horizon. Although Psyence Biomedical's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Psyence Biomedical's systematic risk associated with finding meaningful patterns of Psyence Biomedical fundamentals over time.
  
As of the 29th of November 2024, Payables Turnover is likely to drop to 0.0003. As of the 29th of November 2024, Common Stock Shares Outstanding is likely to grow to about 11.4 M.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Psyence Biomedical works best with periods where there are trends or seasonality.

Psyence Biomedical Double Exponential Smoothing Price Forecast For the 30th of November

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Psyence Biomedical Ltd on the next trading day is expected to be 3.51 with a mean absolute deviation of 0.59, mean absolute percentage error of 0.64, and the sum of the absolute errors of 34.83.
Please note that although there have been many attempts to predict Psyence Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Psyence Biomedical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Psyence Biomedical Stock Forecast Pattern

Backtest Psyence BiomedicalPsyence Biomedical Price PredictionBuy or Sell Advice 

Psyence Biomedical Forecasted Value

In the context of forecasting Psyence Biomedical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Psyence Biomedical's downside and upside margins for the forecasting period are 0.04 and 12.89, respectively. We have considered Psyence Biomedical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
3.51
3.51
Expected Value
12.89
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Psyence Biomedical stock data series using in forecasting. Note that when a statistical model is used to represent Psyence Biomedical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.137
MADMean absolute deviation0.5904
MAPEMean absolute percentage error0.0812
SAESum of the absolute errors34.8344
When Psyence Biomedical Ltd prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Psyence Biomedical Ltd trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Psyence Biomedical observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Psyence Biomedical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Psyence Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.224.3213.71
Details
Intrinsic
Valuation
LowRealHigh
0.173.3712.76
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Psyence Biomedical. Your research has to be compared to or analyzed against Psyence Biomedical's peers to derive any actionable benefits. When done correctly, Psyence Biomedical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Psyence Biomedical.

Other Forecasting Options for Psyence Biomedical

For every potential investor in Psyence, whether a beginner or expert, Psyence Biomedical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Psyence Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Psyence. Basic forecasting techniques help filter out the noise by identifying Psyence Biomedical's price trends.

Psyence Biomedical Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Psyence Biomedical stock to make a market-neutral strategy. Peer analysis of Psyence Biomedical could also be used in its relative valuation, which is a method of valuing Psyence Biomedical by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Psyence Biomedical Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Psyence Biomedical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Psyence Biomedical's current price.

Psyence Biomedical Market Strength Events

Market strength indicators help investors to evaluate how Psyence Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Psyence Biomedical shares will generate the highest return on investment. By undertsting and applying Psyence Biomedical stock market strength indicators, traders can identify Psyence Biomedical Ltd entry and exit signals to maximize returns.

Psyence Biomedical Risk Indicators

The analysis of Psyence Biomedical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Psyence Biomedical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting psyence stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's future performance. For an informed investment choice regarding Psyence Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Psyence Biomedical to cross-verify your projections.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.82)
Return On Assets
(1.26)
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.